Episode 252: Accelerating Medical Advancements with Charles Fisher, CEO and Co-Founder of Unlearn.ai, San Francisco, CA USA

Disruptive CEO Nation

Charles Fisher is a pioneering figure in the application of artificial intelligence to medicine and healthcare. With a PhD in biophysics from Harvard and a robust background in machine learning research, Fisher believes that AI has the potential to revolutionize medicine by addressing complex challenges and he does with the handpicked team he has assembled at Unlearn.ai.

He highlights the rapid advancement of AI technologies, while also acknowledging that the current systems are not yet all-encompassing but improve annually. Fisher emphasizes that high-quality medical datasets are crucial for training effective AI models and views the creation of large datasets as essential for unlocking significant improvements in healthcare.

Here are some highlights are from our chat:

- AI advancements in medicine are underhyped, with rapid progress driven by machine learning technologies, better computers, and data accumulation.

- The medical field lags behind consumer applications in AI due to the need for comprehensive medical datasets for training models effectively.

- Digital twins in healthcare are used to create virtual replicas of patients, improving outcomes and personalizing treatments.

- AI technology can predict outcomes in clinical trials, reducing the need for placebos and making studies more efficient and aligned with patient needs.

- AI has the potential to accelerate medical research, reduce drug development costs, and lead to significant improvements in solving medical problems within the next 5-10 years.

Charles Fisher is the CEO and co-founder of Unlearn.ai Charles is a scientist with interests at the intersection of physics, machine learning, and computational biology. Previously, he worked as a machine learning engineer at Leap Motion and a computational biologist at Pfizer. He was a Philippe Meyer Fellow in theoretical physics at École Normale Supérieure in Paris, France, and a postdoctoral scientist in biophysics at Boston University. Charles holds a Ph.D. in biophysics from Harvard University and a B.S. in biophysics from the University of Michigan.

Connect with Charles:

Website: https://www.unlearn.ai/

LinkedIn: https://www.linkedin.com/in/charleskfisher/

Connect with Allison:

Feedspot has named Disruptive CEO Nation as one of the Top 25 CEO Podcasts on the web and it is ranked the number 10 CEO podcast to listen to in 2024! https://podcasts.feedspot.com/ceo_podcasts/

LinkedIn: https://www.linkedin.com/in/allisonsummerschicago/

Website: https://www.disruptiveceonation.com/

Twitter: @DisruptiveCEO

#CEO #AI #Tech #Enterprise #startup #startupstory #founder #business #businesspodcast #podcast

Learn more about your ad choices. Visit megaphone.fm/adchoices